ANACONDA Trademark

Trademark Overview


On Tuesday, March 24, 2020, a trademark application was filed for ANACONDA with the United States Patent and Trademark Office. The USPTO has given the ANACONDA trademark a serial number of 79283673. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, April 13, 2024. This trademark is owned by Vascutek Limited. The ANACONDA trademark is filed in the Medical Instrument Products category with the following description:

Surgical apparatus and instruments for medical, dental and veterinary purposes; artificial vascular grafts, artificial stent grafts, artificial thoracic, aortic, thoracoabdominal and abdominal stent grafts, surgical hybrid stent grafts for treatment of thoracoabdominal aortic aneurysms, stents, and patches for repair and reconstruction of internal tissue; vascular prostheses; surgical implants comprising artificial materials; suture materials; grafts made primarily of artificial materials being patches for repair and/or reconstruction of internal tissue; implantable medical systems comprised of artificial endovascular stent grafts; implantable medical devices, namely, artificial endovascular stent grafts; implantable medical devices comprising an artificial graft and stent joined together and compacted into a delivery system; artificial vascular grafts; artificial branched vascular grafts; artificial endovascular grafts; surgical graft materials, namely, artificial vascular grafts and ...
anaconda

General Information


Serial Number79283673
Word MarkANACONDA
Filing DateTuesday, March 24, 2020
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, April 13, 2024
Registration Number6375090
Registration DateTuesday, June 8, 2021
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 23, 2021

Trademark Statements


Goods and ServicesSurgical apparatus and instruments for medical, dental and veterinary purposes; artificial vascular grafts, artificial stent grafts, artificial thoracic, aortic, thoracoabdominal and abdominal stent grafts, surgical hybrid stent grafts for treatment of thoracoabdominal aortic aneurysms, stents, and patches for repair and reconstruction of internal tissue; vascular prostheses; surgical implants comprising artificial materials; suture materials; grafts made primarily of artificial materials being patches for repair and/or reconstruction of internal tissue; implantable medical systems comprised of artificial endovascular stent grafts; implantable medical devices, namely, artificial endovascular stent grafts; implantable medical devices comprising an artificial graft and stent joined together and compacted into a delivery system; artificial vascular grafts; artificial branched vascular grafts; artificial endovascular grafts; surgical graft materials, namely, artificial vascular grafts and artificial endovascular grafts; medical systems, namely, stent delivery systems; medical devices comprising an artificial vascular graft and a stent; medical devices comprising an artificial vascular graft, a stent and a delivery system; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in endovascular procedures; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in thoracoabdominal procedures; medical systems and medical devices in the nature of surgical implants comprising artificial material and associated surgical instrument sets for use in aortic arch procedures; thoracic stents; artificial thoracic stent grafts; artificial stent grafts; artificial stent graft systems; artificial stent graft devices; artificial stent graft systems and surgical devices comprising more than one component; artificial stent graft systems and surgical devices comprising components of more than one stent graft; artificial stent graft systems and surgical devices comprising components of more than one type of stent graft; artificial thoracic stent graft systems; artificial thoracoabdominal stent graft systems; artificial thoracic stent graft devices; artificial thoracoabdominal stent graft devices; delivery systems for artificial stent graft systems and artificial stent graft devices; medical systems, namely, minimally invasive devices for aneurysm repair, including thoracoabdominal aortic aneurysm ('TAAA') repair; medical devices, namely, minimally invasive devices for aneurysm repair; including thoracoabdominal aortic aneurysm ('TAAA') repair; artificial cardiac valves for surgical prostheses; cardiac valve replacement systems, namely, artificial cardiac valves; artificial heart valves; artificial heart valve conduits; artificial cardiac patches; artificial vascular patches; artificial cardiovascular patches; artificial thoracic patches; artificial tissue patches; parts and fittings for all of the aforementioned goods

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeH - NOT AVAILABLE
Class Status DateSaturday, April 13, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVascutek Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameVascutek Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameVascutek Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Thursday, April 16, 2020SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Monday, April 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 30, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 24, 2020APPLICATION FILING RECEIPT MAILED
Monday, June 15, 2020ASSIGNED TO EXAMINER
Monday, June 22, 2020NON-FINAL ACTION WRITTEN
Monday, June 22, 2020NON-FINAL ACTION WRITTEN
Tuesday, June 23, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 30, 2020REFUSAL PROCESSED BY MPU
Friday, August 14, 2020REFUSAL PROCESSED BY IB
Friday, January 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 17, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 17, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 17, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, February 17, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 17, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, March 3, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 3, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Sunday, March 21, 2021NOTIFICATION PROCESSED BY IB
Tuesday, March 23, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2021REGISTERED-PRINCIPAL REGISTER
Friday, November 1, 2024DEATH OF INTERNATIONAL REGISTRATION
Friday, November 1, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, October 24, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, September 8, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, September 29, 2021FINAL DISPOSITION PROCESSED
Wednesday, September 29, 2021FINAL DISPOSITION NOTICE SENT TO IB